Vivalyx GmbH

Vivalyx GmbH is an organ vitality technology company working on the organ preservation bottleneck in transplantation medicine. Its stated aim is to increase both the vitality and the number of donor organs available for transplant, with a focus on scalable, practical preservation methods and on reducing complications that arise from suboptimal organ quality.

The company's principal product is Vivalyx Omnisol, a patented, blood-free perfusate for donor organs. It is designed for use across multiple preservation approaches - Static Cold Storage (SCS), Hypothermic Oxygenated Machine Perfusion (HOPE) and Normothermic Machine Perfusion (NMP) - and is intended to replace blood-based formulations in order to make organ preservation more reproducible.

Technical work at Vivalyx spans organ preservation and organ perfusion, transplantation medicine, biotechnology and medical devices, covering both hypothermic and normothermic machine perfusion. The company operates across healthcare, transplantation, medical technology and pharmaceuticals/biotechnology.